nationalvision.com (EYE): Debt to Book Value

America's Best Contacts & Eyeglasses (EYE) - corporate logo

The National Vision Holdings (EYE) business is based on strict licensing control and complex agreements with insurance funds. The delivery of services requires the personal involvement of physicians, making full process automation impossible. The company's pricing evolution demonstrates a metric at the level of 0.74. The stability of the outlook is ensured by the independence of optical retail from global trade conflicts and steady domestic demand in the US.

EYE America's Best Contacts & Eyeglasses: Debt to Book Value in the range 07/04/2022 - 10/30/2026
Original product of America's Best Contacts & Eyeglasses

National Vision Holdings (EYE) maintains an extensive network of optical centers that ensures a stable cash flow, directly impacting the company's ability to service its obligations. The current leverage ratio based on balance sheet capital compares total debt to the market value of equity, allowing investors to perform a real-time assessment of the business's financial stability and insolvency risks without waiting for quarterly reports.

Competitor analysis for National Vision Holdings

Debts to Book Capitalization HCA (HCA Healthcare)|Debts to Book Capitalization tenethealth.com THC|FMS: Debt to Book Value|Solventum Corp - Debt to Book Capital|Encompass Health Inc. (EHC) - Debt to Book Capitalization Ratio|Debt to Book Value Universal Health Services, Inc.|DVA (DaVita Inc.) - Debts to Book Capitalization|Debts to Book Value radnet.com RDNT|Debt to Book Capitalization Ratio Option Care Health, Inc. (OPCH)|Surgery Partners Inc - Debt to Book Value Ratio|Premier Corp - Debt to Book Value|Debt to Book Capital PGNY (Progyny Corp)|ARDT - Debt to Book Capitalization Ratio|SEM (selectmedical.com) - Debt to Book Value Ratio|ASTH: Debts to Book Capitalization|Pediatrix Corp (MD) - Debts to Book Capitalization|Debt to Book Value USPH|PNTG (The Pennant Group Corp) - Debt to Book Capital|Debts to Book Capitalization ORGO|Debts to Net Assets nutexhealth.com|Debt to Book Capitalization Ratio Auna AUNA|SBC Medical Corp (SBC) - Debts to Book Value|EOLS - Debt to Book Capitalization Ratio|CYH (Community Health Corp) - Debt to Book Value Ratio|SKIN: Debts to Book Capitalization|MediWound (MDWD) - Debts to Book Capitalization|Debt to Book Capitalization Ratio biote Corp|Debt to Book Capitalization Ratio JYNT|Debt to Book Value DCGO (DocGo Inc)|PIII (p3hp.org) - Debt to Net Assets Ratio|Gain Therapeutics - Debt to Book Value|EUDA Health Holdings - Debt to Book Capitalization Ratio|Basel Medical Group Limited - Debts to Book Capitalization|Debts to Net Assets CollPlant Biotechnologies CLGN|Cuprina Holdings Ltd (CUPR) - Debt to Book Capitalization Ratio|CCM - Debts to Net Assets|AMS (American Shared Hospital) - Debts to Book Capitalization|medirom.co.jp (MRM) - Debts to Net Assets|Debt to Book Capitalization Ratio Avalon GloboCare (ALBT)|DHAI - Debts to Book Value|Debt to Book Capitalization Ratio Longevity Health Holdings Inc XAGE|NIVF: Debt to Book Value Ratio|ATIP: Debt to Book Value|Debt to Net Assets Ratio CMAX (caremax.com)|KDLY: Debts to Book Capitalization|ModivCare Inc - Debt to Net Assets Ratio|Debt to Book Capitalization Ratio Novo Integrated|Debts to Book Value SunLink Health Systems, Inc SSY|Debt to Book Capitalization Ratio IMAC Holdings, Inc. (BACK)